The Periodontal Therapeutics Market Size was valued at USD 843.6 Mn in 2023 and is predicted to reach USD 1,497.4 Mn by 2031 at a 7.6% CAGR during the forecast period for 2024-2031.
Periodontal disease encompasses a wide range of inflammatory conditions affecting the tissues surrounding the teeth. It primarily includes gingivitis (mild inflammation of the gums) and periodontitis (severe inflammation that can lead to tooth loss). Gingivitis is reversible with the help of proper care, but if it is left untreated, it can lead to periodontitis, which is more challenging to manage. The growth of the market is due to the growing prevalence of periodontal diseases. Increasing awareness about oral health, the rising geriatric population, and technological advancements in dentistry are further propelling the growth of the market. Also, the recommendation of drugs like antibiotics is rising in the same field. It is quite advantageous for the growth of the periodontal market.
The COVID-19 pandemic has significantly impacted the periodontal therapeutics market. Dental clinics and periodontal practices faced temporary closures and reduced patient visits due to lockdowns and social distancing measures. It led to a decline in the demand for periodontal treatments. However, the pandemic also heightened awareness of the importance of oral health, potentially driving future market growth. Telehealth services and remote consultations emerged as alternative approaches, aiding in patient management during the crisis. As restrictions ease and normalcy returns, the market is expected to recover, with an increased focus on infection control and preventive care.
The periodontal therapeutics market is segmented on the basis of disease, drug type, and distributional channel. By Disease type, the market segments include gingivitis, chronic periodontal disease, aggressive periodontal disease, and others. On the basis of drug type, the segments are doxycycline, minocycline, chlorhexidine, metronidazole, and others. By distribution channel, the segmentation includes hospital pharmacies, retail pharmacies, and online channels.
The gingivitis segment of the periodontal therapeutics market is growing due to increased awareness of oral health and the prevalence of gum diseases. Gingivitis, an early stage of periodontal disease, is the inflammation of the gums as well as can lead to many severe conditions if untreated. The market includes various treatment options, such as antiseptic mouthwashes, antibiotics, and professional dental cleanings. Innovations in dental care products and a rising focus on preventive healthcare are driving market growth. Additionally, increased dental visits and advancements in diagnostic tools contribute to the expansion of this segment within the periodontal therapeutics market.
The doxycycline segment of the periodontal therapeutics market is a significant component in treating periodontal diseases. Doxycycline, a type of antibiotic, is commonly used in the form of gel or subgingival fibers to target specific bacteria causing periodontitis. It works by reducing inflammation and inhibiting bacterial growth in the periodontal pockets. The segment is seen to grow due to the effectiveness of doxycycline in managing periodontal conditions, its ease of application, and favorable patient outcomes. With increasing emphasis on oral health and advancements in periodontal treatments, the doxycycline segment plays a crucial role in the periodontal therapeutics market.
North America's periodontal therapeutics market dominates the market. It has been initiated to increase awareness about oral health—the rise in effective procedures for the treatment and diagnosis of periodontal diseases. Hence, the sales of periodontal treatment products, including both drugs and devices, in the region are quite high. Asia Pacific is to be seen to grow at a rapid rate in the global periodontal therapeutics market due to growing concerns about rapid industrialization, government initiatives, and increasing funding in various industries.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 843.6 Mn |
|
Revenue Forecast In 2031 |
USD 1,497.4 Mn |
|
Growth Rate CAGR |
CAGR of 7.6% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Disease, By Drug Type, By Distribution Channel and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Pfizer Inc., Lupin Ltd., Teva Pharmaceuticals USA, Inc., Sun Pharmaceutical Industries Ltd., Tokyo Chemical Industry Co., Ltd., Bausch Health Companies Inc., USAntibiotics, Melinta Therapeutics LLC, Cipla, Inc., Chartwell Pharmaceuticals LLC, and other prominent players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Periodontal Therapeutics Market Snapshot
Chapter 4. Global Periodontal Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Disease Outlook Estimates & Trend Analysis
5.1. Disease Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Outlook:
5.2.1. Gingivitis
5.2.2. Chronic Periodontal Disease
5.2.3. Aggressive Periodontal Disease
5.2.4. Others
Chapter 6. Market Segmentation 2: Drug Type Outlook Estimates & Trend Analysis
6.1. Drug Type Outlook & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Drug Type Outlook:
6.2.1. Doxycycline
6.2.2. Minocycline
6.2.3. Chlorhexidine
6.2.4. Metronidazole
6.2.5. Other drug types
Chapter 7. Market Segmentation 3: Distribution Channel Outlook Estimates & Trend Analysis
7.1. Distribution Channel Outlook & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channel Outlook:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Channel
Chapter 8. Periodontal Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.1.2. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.1.3. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.1.4. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.2.2. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.2.3. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.2.4. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.3.2. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.3.3. Asia-Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.3.4. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.4.2. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.4.3. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.4.4. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.5.2. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.5.3. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.5.4. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.2. Lupin Ltd
9.2.3. Teva Pharmaceuticals USA, Inc.
9.2.4. Sun Pharmaceutical Industries Ltd.
9.2.5. Tokyo Chemical Industry Co., Ltd.
9.2.6. Bausch Health Companies Inc.
9.2.7. USAntibiotics
9.2.8. Melinta Therapeutics LLC
9.2.9. Cipla, Inc.
9.2.10. Chartwell Pharmaceuticals LLC.
Periodontal Therapeutics Market - By Disease
Periodontal Therapeutics Market - By Drug Type
Periodontal Therapeutics Market - By Distribution Channel
Periodontal Therapeutics Market - By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
